Detalhe da pesquisa
1.
Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin.
Cell
; 136(3): 551-64, 2009 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-19185337
2.
Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's disease.
Alzheimers Dement
; 20(2): 1102-1111, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882364
3.
Single-timepoint low-dimensional characterization and classification of acute versus chronic multiple sclerosis lesions using machine learning.
Neuroimage
; 265: 119787, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473647
4.
Recurrent disability progression endpoints in multiple sclerosis clinical trials.
Mult Scler
; 29(1): 130-139, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177953
5.
Lesion-level correspondence and longitudinal properties of paramagnetic rim and slowly expanding lesions in multiple sclerosis.
Mult Scler
; 29(6): 680-690, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37036134
6.
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
Mult Scler
; 29(9): 1070-1079, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37317870
7.
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysis.
Alzheimers Dement
; 19(4): 1292-1299, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36043526
8.
Overall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.
Mult Scler
; 28(14): 2263-2273, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36131595
9.
A smartphone sensor-based digital outcome assessment of multiple sclerosis.
Mult Scler
; 28(4): 654-664, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34259588
10.
Digital Devices for Assessing Motor Functions in Mobility-Impaired and Healthy Populations: Systematic Literature Review.
J Med Internet Res
; 24(11): e37683, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36409538
11.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
N Engl J Med
; 376(3): 221-234, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28002679
12.
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
N Engl J Med
; 376(3): 209-220, 2017 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28002688
13.
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
Brain
; 142(9): 2787-2799, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31497864
14.
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
Ann Neurol
; 84(4): 527-536, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30155979
15.
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
Mult Scler
; 25(14): 1915-1925, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566027
16.
Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
J Med Internet Res
; 21(10): e16287, 2019 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31596725
17.
Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
J Med Internet Res
; 21(8): e14863, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471961
18.
Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study.
Mult Scler
; 24(7): 963-973, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28554238
19.
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial.
Mult Scler
; 24(14): 1862-1870, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415593
20.
Toward the end of a controversy on the effect of reduction in brain amyloid levels on change in cognitive and functional decline in Alzheimer's disease-Reply to a letter.
Alzheimers Dement
; 2022 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36383475